Philips Stock Falls After Company Cuts Margin Guidance, Citing Tariffs

Philips Stock Falls After Company Cuts Margin Guidance, Citing Tariffs

Philips Stock Falls After Company Cuts Margin Guidance, Citing Tariffs

Advisor Insight

Shares of medical equipment company Koninklijke Philips (

PHG

) shares are dropping Tuesday after the Dutch conglomerate said it had cut its target profit margin due to tariffs.

The company, which announced the new guidance as it posted better-than-expected quarterly sales, said it was reducing its full-year adjusted
earnings before interest, taxes, and amortization (EBITA)
margin target. Its first-quarter adjusted EBITA margin had fallen 80
basis points
year-over-year to 8.6%.

“Philips’ outlook for full year 2025 is updated to include the assumed impact of currently announced tariffs,” the company said, citing an “uncertain macro environment.”

“This includes current bilateral US-China and rest of world tariffs, the resumption of the paused US tariffs on July 9 and excludes potential wider economic impact,” the company said. It kept its comparable sales growth forecast unchanged at between 1% and 3%.

The company said it projects its full-year adjusted EBITA margin range to be 10.8%-11.3%, including an estimated net tariff impact of 250-300 million euros after  “substantial tariff mitigations.” That amounts to a 100 bps reduction versus the previous forecast.

The lowered guidance comes as the company posted first-quarter sales that beat analysts’ estimates. The company posted revenue of 4.1 billion euros versus a 4 billion euros consensus forecast from analysts polled by Visible Alpha.

The company’s shares are down a bit more than 2% this year.

Read the original article on
Investopedia

Leave a Reply

Your email address will not be published. Required fields are marked *

THIS CONTENT IS CURRENTLY LOCKED.

ApexDator is scheduled to launch in 2026.

Contact the organization’s assistant to receive early access and related benefits in advance, including AI-powered stock picks, signals, and expert-backed research as features roll out.